Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 397-408 of 4,306
Drug study icon
Not Yet RecruitingNCT06651112

The ATP Project (Antipsychotic-TEP-Psychosis)

This summary needs review. Please check the official study record and contact the research team for details.

In Sherbrooke
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 35 Years
Countries
Canada
Sponsor
Université de Sherbrooke
Condition
Schizophrenia
Drug study icon
Enrolling By InvitationNCT06194799

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Costa Mesa
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 95 Years
Countries
United States, France, Brazil, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
Enrolling By InvitationNCT07459660

An Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

This study is enrolling by invitation in the United States, in France, and in Bulgaria. It is testing ML-007C-MA for Schizophrenia.

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 91 Years
Countries
United States, France, Bulgaria
Sponsor
MapLight Therapeutics
Condition
Schizophrenia
Drug study icon
Enrolling By InvitationNCT07095465

Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

This study is enrolling by invitation in the United States, in France, in Bulgaria, .... It is testing ACP-204 for Schizophrenia.

Multiple locations, including Irvine
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 84 Years
Countries
United States, France, Bulgaria, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT07085923

Norwegian Mental Illness Heart Health Study

This summary needs review. Please check the official study record and contact the research team for details.

In Oslo
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityBehavioralFrom 25 Years to 70 Years
Countries
Norway
Sponsor
Madeleine Elisabeth Angelsen
Condition
Schizophrenia, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.